Latest oppositions filed by Glaxo Group Limited

This table presents recent patent oppositions filed by Glaxo Group Limited against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3459578Dispensing DevicePFIZER LIMITEDDec 2, 2021
EP3057612Method Of Obtaining Thermostable Dried Vaccine FormulationsMERCK SHARP & DOHME CORP.Feb 5, 2021
EP2266549Method Of Making Particles For Use In A Pharmaceutical CompositionVECTURA LIMITEDMay 6, 2020
EP2298279Pharmaceutical Compositions For InhalationVECTURA LIMITEDAug 12, 2019
EP2752216Dispensing DevicePFIZER LIMITEDJul 19, 2019
EP2708558Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 18, 2018
EP2708559Antigen-Binding Molecule Capable Of Binding To Two Or More Antigen Molecules RepeatedlyCHUGAI SEIYAKU KABUSHIKI KAISHADec 18, 2018
EP2188371Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In BioreactorsWYETH LLCSep 20, 2018
EP2586788Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH, INC.Aug 27, 2018
EP2283818Method Of Making Particles For Use In A Pharmaceutical CompositionVECTURA LIMITEDMay 1, 2018

The following table provides an overview of the latest patents of Glaxo Group Limited that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3578169Jun 26, 2024Pharmaceutical Formulations Comprising 4-{(1 R)-2-[(6-{2-[(2,6-Dichlorobenzyl)Oxy]Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2-(Hydroxymethyl)Phenol1
EP1907037Sep 7, 2022Medicament Dispenser1
EP2005372May 18, 2022Counter For Use With A Medicament Dispenser1
EP3199164Mar 18, 2020Processes For Making Lactose Utilizing Pre-Classification Techniques And Pharmaceutical Formulations Formed Therefrom1
EP2400950May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)Phenol8
EP2506844Dec 20, 2017Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist3
EP2512491Oct 11, 2017Hbv Antisense Inhibitors1